EMD-16397

Single-particle
2.56 Å
EMD-16397
3D View Gallery
Deposition: 22/12/2022
Map released: 22/05/2024
Last modified: 04/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16397

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8c2r summary report (pdf.gz) Map-8c2r FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody

EMD-16397

Single-particle
2.56 Å
EMD-16397
3D View Gallery
Deposition: 22/12/2022
Map released: 22/05/2024
Last modified: 04/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens, Enterobacteria phage T4
Sample: SARS-CoV2 Omicron BA.1 Spike in complex with CAB-A17 antibody
Fitted models: 8c2r

Deposition Authors: Das H, Hallberg BM
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies.
Sheward DJ , Pushparaj P , Das H, Greaney AJ, Kim C, Kim S, Hanke L, Hyllner E, Dyrdak R, Lee J, Dopico XC, Dosenovic P , Peacock TP , McInerney GM, Albert J, Corcoran M, Bloom JD, Murrell B , Karlsson Hedestam GB, Hallberg BM
(2024) Cell Rep Med , 5 , 101577 - 101577
PUBMED: 38761799
DOI: doi:10.1016/j.xcrm.2024.101577
ISSN: 2666-3791
Grant Support: